Home › Funds › D. E. Shaw & Co › ORGO
D. E. Shaw & Co position in ORGO
ORGANOGENESIS HLDGS INC · Health Care
Latest position (Q2 2026)2.89M sh
Reported value held$7.02M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 133.32K | $1.90M | New |
| Q4 2021 | 76.50K | $707.00K | Reduce |
| Q1 2022 | 63.77K | $486.00K | Reduce |
| Q2 2022 | 151.25K | $738.00K | Add |
| Q3 2022 | 194.78K | $631.00K | Add |
| Q4 2022 | 431.84K | $1.16M | Add |
| Q1 2023 | 1.34M | $2.86M | Add |
| Q2 2023 | 1.27M | $4.22M | Reduce |
| Q3 2023 | 1.09M | $3.45M | Reduce |
| Q4 2023 | 966.87K | $3.95M | Reduce |
| Q1 2024 | 632.74K | $1.80M | Reduce |
| Q2 2024 | 741.93K | $2.08M | Add |
| Q3 2024 | 738.12K | $2.11M | Reduce |
| Q4 2024 | 737.44K | $2.36M | Hold |
| Q1 2025 | 884.29K | $3.82M | Add |
| Q2 2025 | 613.06K | $2.24M | Reduce |
| Q3 2025 | 511.64K | $2.16M | Reduce |
| Q4 2025 | 1.99M | $10.30M | Add |
| Q1 2026 | 2.30M | $5.45M | Add |
| Q2 2026 | 2.89M | $7.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORGO
- Morgan Stanley 11.72M sh · $28.48M · Q2 2026
- Vanguard Group 4.96M sh · $25.69M · Q4 2025
- BlackRock Inc 7.25M sh · $17.62M · Q2 2026
- AQR Capital Management 3.01M sh · $7.32M · Q2 2026
- Geode Capital Management 1.94M sh · $4.70M · Q2 2026
- Deutsche Bank AG 1.71M sh · $4.15M · Q2 2026
- Renaissance Technologies 1.02M sh · $2.47M · Q2 2026
- Charles Schwab Investment Management 905.02K sh · $2.20M · Q2 2026
- Goldman Sachs Group 887.40K sh · $2.16M · Q2 2026
- Citadel Advisors 867.93K sh · $2.11M · Q2 2026
- Northern Trust Corp 584.58K sh · $1.42M · Q2 2026